Latest News

New leadership for the Department of Health January 23, 2020

The Commonwealth Department of Health has a new secretary with incumbent Glenys Beauchamp PSM announcing her retirement from the Australian Public Service after more than two decades.

PolyNovo announces European shipments of NovoSorb BTM January 23, 2020

PolyNovo (ASX:PNV) has announced it has received the first orders of NovoSorb BTM from PMI for use in Germany, Austria and Switzerland.

New director for BARD1 Life Sciences January 23, 2020

BARD1 Life Sciences (ASX:BD1), a medical technology company developing non-invasive cancer diagnostics, has announced the appointment of prominent Australian scientist Professor Allan Cripps as an Independent Non-Executive Director.

Admedus announces new trial of ADAPT as surgical aortic valve replacement January 23, 2020

Admedus (ASX:AHZ) has announced the approval for first-in-human surgical aortic valve replacement (SAVR) trial of its proprietary ADAPT single-piece 3D aortic valve at the Leuven University Hospitals.

MTPConnect appoints experienced industry and R&D executive January 21, 2020

MTPConnect has appointed experienced industry and R&D executive Alex Fowkes as a new non-executive director.

China backs stronger biopharma IP in US trade deal January 21, 2020

The recently negotiated Economic and Trade Agreement between the US and China has delivered significant outcomes on pharmaceutical patent protection and sets the scene for an ongoing global debate over data protection.

Data on PAT-DX1 to be presented at international summit January 21, 2020

Patrys (ASX:PAB), an Australian therapeutic antibody development company, has announced the upcoming presentation of scientific data regarding its lead candidate, PAT-DX1.

European approval for QBiotics tigilanol tiglate January 21, 2020

Australian company QBiotics has announced the first registration for its small molecule, tigilanol tiglate, with the European Medicines Agency approval of STELFONTA as an oncology veterinary pharmaceutical.

Roche-Sarepta deal a positive sign for Australian access January 16, 2020

One of the world's leading gene therapy companies recently entered a global collaboration with Roche that could see Australian patients gain timely access to an emerging curative treatment for Duchenne muscular dystrophy.

Orthocell reports R&D Tax Incentive refund January 16, 2020

Regenerative medicine company Orthocell (ASX:OCC) has reported a Research and Development (R&D) Tax Incentive refund of $2,904,545 for the financial year 2018/2019.

PainChek secures Japanese patent and progresses expansion January 16, 2020

Australian company PainChek (ASX:PCK) says it been granted a patent in Japan for its smartphone pain assessment and monitoring technology.

Federal government invests in STEM grants January 16, 2020

The federal government has announced the opening of applications for the $2 million Community STEM Engagement Grants Maker Projects program.

Most Read

MTPConnect appoints experienced industry and R&D executive

AusBiotech seeks industry’s views and policy priorities

Data on PAT-DX1 to be presented at international summit

European approval for QBiotics tigilanol tiglate

China backs stronger biopharma IP in US trade deal

New Stories

New leadership for the Department of Health

PolyNovo announces European shipments of NovoSorb BTM

New director for BARD1 Life Sciences

Admedus announces new trial of ADAPT as surgical aortic valve replacement

Global regenerative medicine industry poised for continued expansion

MTPConnect appoints experienced industry and R&D executive

AusBiotech seeks industry’s views and policy priorities

Sign In

Most Read

MTPConnect appoints experienced industry and R&D executive

AusBiotech seeks industry’s views and policy priorities

Data on PAT-DX1 to be presented at international summit

European approval for QBiotics tigilanol tiglate

China backs stronger biopharma IP in US trade deal

Follow Us

New Stories

New leadership for the Department of Health

PolyNovo announces European shipments of NovoSorb BTM

New director for BARD1 Life Sciences

Admedus announces new trial of ADAPT as surgical aortic valve replacement

Global regenerative medicine industry poised for continued expansion

MTPConnect appoints experienced industry and R&D executive

AusBiotech seeks industry’s views and policy priorities